Literature DB >> 21753150

IFN-β mediates suppression of IL-12p40 in human dendritic cells following infection with virulent Francisella tularensis.

Timothy J Bauler1, Jennifer C Chase, Catharine M Bosio.   

Abstract

Active suppression of inflammation is a strategy used by many viral and bacterial pathogens, including virulent strains of the bacterium Francisella tularensis, to enable colonization and infection in susceptible hosts. In this study, we demonstrated that virulent F. tularensis strain SchuS4 selectively inhibits production of IL-12p40 in primary human cells via induction of IFN-β. In contrast to the attenuated live vaccine strain, infection of human dendritic cells with virulent SchuS4 failed to induce production of many cytokines associated with inflammation (e.g., TNF-α and IL-12p40). Furthermore, SchuS4 actively suppressed secretion of these cytokines. Assessment of changes in the expression of host genes associated with suppression of inflammatory responses revealed that SchuS4, but not live vaccine strain, induced IFN-β following infection of human dendritic cells. Phagocytosis of SchuS4 and endosomal acidification were required for induction of IFN-β. Further, using a defined mutant of SchuS4, we demonstrated that the presence of bacteria in the cytosol was required, but not sufficient, for induction of IFN-β. Surprisingly, unlike previous reports, induction of IFN-β by F. tularensis was not required for activation of the inflammasome, was not associated with exacerbation of inflammatory responses, and did not control SchuS4 replication when added exogenously. Rather, IFN-β selectively suppressed the ability of SchuS4-infected dendritic cells to produce IL-12p40. Together, these data demonstrated a novel mechanism by which virulent bacteria, in contrast to attenuated strains, modulate human cells to cause disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21753150      PMCID: PMC3150225          DOI: 10.4049/jimmunol.1100377

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  54 in total

1.  Prophylactic effectiveness of live and killed tularemia vaccines. I. Production of vaccine and evaluation in the white mouse and guinea pig.

Authors:  H T EIGELSBACH; C M DOWNS
Journal:  J Immunol       Date:  1961-10       Impact factor: 5.422

2.  Tularemia vaccine study. II. Respiratory challenge.

Authors:  S SASLAW; H T EIGELSBACH; J A PRIOR; H E WILSON; S CARHART
Journal:  Arch Intern Med       Date:  1961-05

Review 3.  The yin and yang of type I interferon activity in bacterial infection.

Authors:  Thomas Decker; Mathias Müller; Silvia Stockinger
Journal:  Nat Rev Immunol       Date:  2005-09       Impact factor: 53.106

Review 4.  Dendritic cells and the control of immunity.

Authors:  J Banchereau; R M Steinman
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

5.  Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development.

Authors:  B L McRae; R T Semnani; M P Hayes; G A van Seventer
Journal:  J Immunol       Date:  1998-05-01       Impact factor: 5.422

6.  Francisella tularensis LVS initially activates but subsequently down-regulates intracellular signaling and cytokine secretion in mouse monocytic and human peripheral blood mononuclear cells.

Authors:  Max Telepnev; Igor Golovliov; Anders Sjöstedt
Journal:  Microb Pathog       Date:  2005-04-21       Impact factor: 3.738

7.  Growth of Francisella tularensis LVS in macrophages: the acidic intracellular compartment provides essential iron required for growth.

Authors:  A H Fortier; D A Leiby; R B Narayanan; E Asafoadjei; R M Crawford; C A Nacy; M S Meltzer
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

8.  Salmonella enterica serovar Typhimurium pathogenicity island 2 is necessary for complete virulence in a mouse model of infectious enterocolitis.

Authors:  Bryan Coburn; Yuling Li; David Owen; Bruce A Vallance; B Brett Finlay
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

9.  Virulent and avirulent strains of Francisella tularensis prevent acidification and maturation of their phagosomes and escape into the cytoplasm in human macrophages.

Authors:  Daniel L Clemens; Bai-Yu Lee; Marcus A Horwitz
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

10.  TLR4 signaling is essential for survival in acute lung injury induced by virulent Pseudomonas aeruginosa secreting type III secretory toxins.

Authors:  Karine Faure; Teiji Sawa; Temitayo Ajayi; Junichi Fujimoto; Kiyoshi Moriyama; Nobuaki Shime; Jeanine P Wiener-Kronish
Journal:  Respir Res       Date:  2004-02-12
View more
  23 in total

1.  The impact of ISGylation during Mycobacterium tuberculosis infection in mice.

Authors:  Jacqueline M Kimmey; Jessica A Campbell; Leslie A Weiss; Kristen J Monte; Deborah J Lenschow; Christina L Stallings
Journal:  Microbes Infect       Date:  2017-01-10       Impact factor: 2.700

2.  NLRP3 inflammasome pathway has a critical role in the host immunity against clinically relevant Acinetobacter baumannii pulmonary infection.

Authors:  N Dikshit; S D Kale; H J Khameneh; V Balamuralidhar; C Y Tang; P Kumar; T P Lim; T T Tan; A L Kwa; A Mortellaro; B Sukumaran
Journal:  Mucosal Immunol       Date:  2017-06-14       Impact factor: 7.313

3.  Hematopoietic MyD88 and IL-18 are essential for IFN-γ-dependent restriction of type A Francisella tularensis infection.

Authors:  Jerod A Skyberg; Carolyn A Lacey
Journal:  J Leukoc Biol       Date:  2017-09-26       Impact factor: 4.962

4.  Type I interferons: diversity of sources, production pathways and effects on immune responses.

Authors:  Melissa Swiecki; Marco Colonna
Journal:  Curr Opin Virol       Date:  2011-11-25       Impact factor: 7.090

5.  Editorial: Leukocytes in tularemia--so many cells, so little time.

Authors:  Lee-Ann H Allen
Journal:  J Leukoc Biol       Date:  2013-05       Impact factor: 4.962

6.  Virulent Francisella tularensis destabilize host mRNA to rapidly suppress inflammation.

Authors:  Timothy J Bauler; Jennifer C Chase; Tara D Wehrly; Catharine M Bosio
Journal:  J Innate Immun       Date:  2014-05-27       Impact factor: 7.349

Review 7.  Subversion of host recognition and defense systems by Francisella spp.

Authors:  Crystal L Jones; Brooke A Napier; Timothy R Sampson; Anna C Llewellyn; Max R Schroeder; David S Weiss
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

8.  The Early Dendritic Cell Signaling Induced by Virulent Francisella tularensis Strain Occurs in Phases and Involves the Activation of Extracellular Signal-Regulated Kinases (ERKs) and p38 In the Later Stage.

Authors:  Ivo Fabrik; Marek Link; Daniela Putzova; Lenka Plzakova; Zuzana Lubovska; Vlada Philimonenko; Ivona Pavkova; Pavel Rehulka; Zuzana Krocova; Pavel Hozak; Marina Santic; Jiri Stulik
Journal:  Mol Cell Proteomics       Date:  2017-10-18       Impact factor: 5.911

9.  B1a cells enhance susceptibility to infection with virulent Francisella tularensis via modulation of NK/NKT cell responses.

Authors:  Deborah D Crane; Amanda J Griffin; Tara D Wehrly; Catharine M Bosio
Journal:  J Immunol       Date:  2013-02-01       Impact factor: 5.422

10.  Interleukin-17 protects against the Francisella tularensis live vaccine strain but not against a virulent F. tularensis type A strain.

Authors:  Jerod A Skyberg; Maryclare F Rollins; Joshua W Samuel; Marjorie D Sutherland; John T Belisle; David W Pascual
Journal:  Infect Immun       Date:  2013-06-17       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.